Cardioprotection with volatile anesthetics in cardiac surgery

Asian Cardiovascular and Thoracic Annals

Volumn 16, Issue 3, 2008, Pages 256-264

  Lorsomradee, Suraphong ^a   Cromheecke, Stefanie ^a   Lorsomradee, Sratwadee ^a   De Hert, Stefan G ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DESFLURANE; ENFLURANE; FENTANYL; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT; ISOFLURANE; MIDAZOLAM; ORAL ANTIDIABETIC AGENT; PROPOFOL; SEVOFLURANE; SULFONYLUREA DERIVATIVE;

BRAIN PROTECTION; CARDIOPULMONARY BYPASS; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG CHOICE; DRUG EFFECT; HEART ARRHYTHMIA; HEART DEATH; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART SURGERY; HUMAN; MORBIDITY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; RENAL PROTECTION; REPERFUSION INJURY; REVIEW; SURGICAL MORTALITY; UNSTABLE ANGINA PECTORIS;

EID: 48249103897     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/021849230801600319     Document Type: Review

References (67)

1. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 1990;323:1781-8.
2. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990;72:153-84.
3. Warltier DC, Pagel PS, Kersten JR. Approaches to the prevention of perioperative myocardial ischemia [Review]. Anesthesiology 2000;92:253-9.
4. De Hert SG, Van der Linden PJ, ten Broecke PW, Vermeylen KT, Rodrigus IE, Stockman BA. Effects of desflurane and sevoflurane on length-dependent regulation of myocardial function in coronary surgery patients. Anesthesiology 2001;95:357-63.
5. Hu G, Vasiliauskas T, Salem MR, Rhone DP, Crystal GJ. Neutrophils pretreated with volatile anesthetics lose ability to cause cardiac dysfunction. Anesthesiology 2003;98:712-8.
6. Kowalski C, Zahler S, Becker BF, Flaucher A, Conzen PF, Gerlach E, et al. Halothane, isoflurane, and sevoflurane reduce postischaemic adhesion of neutrophils in the coronary system. Anesthesiology 1997;86:188-95.
7. Mitsuhata H, Shimizu R, Yokoyama MM. Suppressive effects of volatile anesthetics on cytokine release in human peripheral blood mononuclear cells. Int J Immunopharmacol 1995;17:529-34.
8. Louvier N, Lancon JP. Do halogenated anesthetics protect from ischemic and reperfusion myocardial injuries? Ann Fr Anesth Reanim 1994;13:690-8.
9. Tanguay M, Blaise G, Dumont L, Beique G, Hollmann C. Beneficial effects of volatile anesthetics on decrease in coronary flow and myocardial contractility induced by oxygen-derived free radicals in isolated rabbit hearts. J Cardiovasc Pharmacol 1991;18:863-70.
10. Heindl B, Conzen PF, Becker BF. The volatile anesthetic sevoflurane mitigates cardiodepressive effects of platelets in reperfused hearts. Basic Res Cardiol 1999;94:102-11.
11. Heindl B, Becker BF, Zahler S, Conzen PF. Volatile anaesthetics reduce adhesion of blood platelets under low-flow conditions in the coronary system of isolated guinea pig hearts. Acta Anaesthesiol Scand 1998;42:995-1003.
12. Heindl B, Reichle FM, Zahler S, Conzen PF, Becker BF. Sevoflurane and isoflurane protect the reperfused guinea pig heart by reducing postischemic adhesion of polymorphonuclear neutrophils. Anesthesiology 1999;91:521-30.
13. Feng J, Fischer G, Lucchinetti F, Zhu M, Bestmann L, Jegger D, et al. Infarct-remodeled myocardium is receptive to protection by isoflurane postconditioning: role of protein kinase B/Akt signaling. Anesthesiology 2006;104:1004-14.
14. Feng J, Lucchinetti E, Ahuja P, Pasch T, Perriard JC, Zaugg M. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta. Anesthesiology 2005;103:987-95.
15. Sommerschild HT, Kirkeboen KA. Preconditioning-endogenous defense mechanisms of the heart. Acta Anaesthesiol Scand 2002;46:123-37.
16. Kato R, Foëx P. Myocardial protection by anesthetic agent against ischemia-reperfusion injury: an update for anesthesiologist [Review]. Can J Anaesth 2002;49:777-91.
17. Tanaka K, Ludwig LM, Kersten JR, Pagel PS, Warltier DC. Mechanisms of cardioprotection by volatile anesthetics [Review]. Anesthesiology 2004;100:707-21.
18. De Hert SG, Turani F, Mathur S, Stowe DF. Cardioprotection with volatile anesthetics: mechanisms and clinical implications Anesth Analg 2005;100:1584-93.
19. de Ruijter W, Musters RJ, Boer C, Stienen GJ, Simonides WS, de Lange JJ. The cardioprotective effect of sevoflurane depends on protein kinase C activation, opening of mitochondrial K(+)(ATP) channels, and the production of reactive oxygen species. Anesth Analg 2003;97:1370-6.
20. Hanouz JL, Yvon A, Massetti M, Lepage O, Babatasi G, Khayat A, et al. Mechanisms of desflurane-induced preconditioning in isolated human right atria in vitro. Anesthesiology 2002;97:33-41.
21. Hara T, Tomiyasu S, Sungsam C, Fukusaki M, Sumikawa K. Sevoflurane protects stunned myocardium through activation of mitochondrial ATP-sensitive potassium channels. Anesth Analg 2001; 92:1139-45.
22. Nakae Y, Kohro S, Hogan QH, Bosnjak ZJ. Intracellular mechanism of mitochondrial adenosine triphosphate-sensitive potassium channel activation with isoflurane. Anesth Analg 2003;97:1025-32.
23. Zaugg M, Lucchinetti E, Spahn DR, Pasch T, Schaub MC. Volatile anesthetics mimic cardiac preconditioning by priming the activation of mitochondrial K(ATP) channels via multiple signaling pathways. Anesthesiology 2002;97:4-14.
24. Zaugg M, Lucchinetti E, Spahn DR, Pasch T, Garcia C, Schaub M. Differential effects of anesthetics on mitochondrial K(ATP) channel activity and cardiomyocyte protection. Anesthesiology 2002;97:15-23.
25. Mullenheim J, Ebel D, Frassdorf J, Preckel B, Thamer V, Schlack W. Isoflurane preconditions myocardium against infarction via release of free radicals. Anesthesiology 2002;96:934-40.
26. Tanaka K, Weihrauch D, Kehl F, Ludwig LM, LaDisa JF Jr, Kersten JR, et al. Mechanism of preconditioning by isoflurane in rabbits: a direct role for reactive oxygen species. Anesthesiology 2002;97:1485-90.
27. Fujimoto K, Bosnjak ZJ, Kwok WM. Isoflurane-induced facilitation of the cardiac sarcolemmal K(ATP) channel. Anesthesiology 2002;97:57-65.
28. Novalija F, Kevin LG, Camara AK, Bosnjak ZJ, Kampine JP, Stowe DF. Reactive oxygen species precede the epsilon isoform of protein kinase C in the anesthetic preconditioning signaling cascade. Anesthesiology 2003;99:421-8.
29. Stadnicka A, Kwok WM, Warltier DC, Bosnjak ZJ. Protein tyrosine kinase-dependent modulation of isoflurane effects on cardiac sarcolemmal K(ATP) channel. Anesthesiology 2002;97: 1198-208.
30. Weber NC, Toma O, Wolter JI, Wirthle NM, Schlack W, Preckel B. Mechanisms of xenon- and isoflurane-induced preconditioning - a potential link to the cytoskeleton via the MAPKAPK-2/HSP27 pathway. Br J Pharmacol 2005;146:445-55.
31. 2+ loading in intact hearts. Anesthesiology 2002;96:125-33.
32. Novalija E, Fujita S, Kampine JP, Stowe DF. Sevoflurane mimics ischemic preconditioning effects on coronary flow and nitric oxide release in isolated hearts. Anesthesiology 1999;91:701-12.
33. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasché P. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999;100(Suppl II):340-4.
34. Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology 2003;98:1315-27.
35. Garcia C, Julier K, Bestmann L, Zollinger A, von Segesser LK, Pasch T, et al. Preconditioning with sevoflurane decreases PFCAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery. Br J Anaesth 2005;94:159-65.
36. Pouzet B, Lecharny JB, Dehoux M, Paquin S, Kitakaze M, Mantz J, et al. Is there a place for preconditioning during cardiac operations in humans? Ann Thorac Surg 2002;73:843-8.
37. Penta de Peppo A, Polisca P, Tomai F, De Paulis R, Turani F, Zupancich E, et al. Recovery of LV contractility in man is enhanced by preischemic administration of enflurane. Ann Thorac Surg 1999;68:112-8.
38. Tomai F, De Paulis R, Penta de Peppo A, Colagrande L, Caprara E, Polisca P, et al. Beneficial impact of isoflurane during coronary bypass surgery on troponin I release. G Ital Cardiol 1999;29:1007-14.
39. Haroun-Bizri S, Khoury SS, Chehab IR, Kassas CM, Baraka A. Does isoflurane optimize myocardial protection during cardiopulmonary bypass? J Cardiothorac Vasc Anesth 2001;15:418-21.
40. Fellahi JL, Gue X, Philippe F, Riou B, Gerard JL. Isoflurane may not influence postoperative cardiac troponin I release and clinical outcome in adult cardiac surgery. Eur J Anaesthesiol 2004;21:688-93.
41. Yvon A, Hanouz JL, Haelewyn B, Terrien X, Massetti M, Babatasi G, et al. Mechanisms of sevoflurane-induced myocardial preconditioning in isolated human right atria in vitro. Anesthesiology 2003;99:27-33.
42. Nader ND, Li CM, Khadra WZ, Reedy R, Panos AL. Anesthetic myocardial protection with sevoflurane. J Cardiothorac Vasc Anesth 2004;18:269-74.
43. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004;101:299-310.
44. De Hert SG, ten Broecke PW, Mertens E, Van Sonimeren EW, De Blier IG, Stockman BA, et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002;97:42-9.
45. De Hert SG, Cromheecke S, ten Broecke PW, Mertens E, De Blier IG, Stockman BA, et al. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology 2003;99:314-23.
46. Van der Linden PJ, Daper A, Trenchant A, De Hert SG. Cardioprotective effects of volatile anesthetics in cardiac surgery. Anesthesiology 2003;99:516-7.
47. Conzen PF, Fischer S, Detter C, Peter K. Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology 2003;99:826-33.
48. Bein B, Renner J, Caliebe D, Scholz J, Paris A, Fraund S, et al. Sevoflurane but not propofol preserves myocardial function during minimally invasive direct coronary artery bypass surgery. Anesth Analg 2005;100:610-6.
49. Guarracino F, Landoni G, Tritapepe L, Pompei F, Leoni A, Aletti G, et al. Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study. J Cardiothorac Vasc Anesth 2006;20:477-83.
50. Law-Koune JD, Raynaud C, Liu N, Dubois C, Romano M, Fischler M. Sevoflurane-remifentanil versus propofol-remifentanil anesthesia at a similar bispectral level for off-pump coronary artery surgery: no evidence of reduced myocardial ischemia. J Cardiothorac Vasc Anesth 2006;20:484-92.
51. El Azab SR, Rosseel PM, De Lange JJ, Groeneveld AB, Van Strik R, Van Wijk EM, et al. Effect of sevoflurane on the ex vivo secretion of TNF-alpha during and after coronary artery bypass surgery. Eur J Anaesthesiol 2003;20:380-4.
52. Lu CC, Ho ST, Wang JJ, Wong CS, Tsai CS, Chang SY, et al. Minimal low-flow isoflurane-based anesthesia benefits patients undergoing coronary revascularization via preventing hyperglycemia and maintaining metabolic homeostasis. Acta Anaesthesiol Sin 2003;41:165-72.
53. Parker FC, Story DA, Poustie S, Liu G, McNicol L. Time to tracheal extubation after coronary artery surgery with isoflurane, sevoflurane, or target-controlled propofol anesthesia: a prospective, randomized, controlled trial. J Cardiothorac Vasc Anesth 2004;18:613-9.
54. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, ten Broecke PW, De Blier IG, et al. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 2004;101:9-20.
55. Cromheecke S, Pepermans V, Hendrickx E, Lorsomradee S, ten Broecke PW, Stockman BA, et al. Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass. Anesth Analg 2006;103:289-96.
56. Lorsomradee S, Cromheecke S, Lorsomradee S, De Hert SG. Effects of sevoflurane on biomechanical markers of hepatic and renal dysfunction after coronary artery surgery. J Cardiothorac Vasc Anesth 2006;20:684-90.
57. Yu CH, Beattie WS. The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis. Can J Anesth 2006;53:906-18.
58. Symons JA, Myles PS. Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth 2006;97:127-36.
59. Cromheecke S, ten Broecke PW, Hendrickx E, Meeus R, De Hert SG. Incidence of atrial fibrillation early after cardiac surgery: can choice of the anesthetic regimen influence the incidence? Acta Anaesthesiol Belg 2005;56:147-54.
60. Hemmerling TM, Choucri E, Noel M, Olivier J, Prieto I. Desflurane causes more atrial fibrillation and tachycardia after off-pump aorto-coronary bypass grafting (OPCAB) than sevoflurane. Anesth Analg 2006;102:S-49. Available at: http://www.iars.org/abstracts/80th%20Abstracts/ 80C%20Abstract%20Supplement%20Final.pdf Accessed March 23 2007.
61. Ludwig LM, Patel HH, Gross GJ, Kersten JR, Pagel PS, Warltier DC. Morphine enhances pharmacological preconditioning by isoflurane: role of mitochondrial K(ATP) channels and opioid receptors. Anesthesiology 2003;98:705-11.
62. Forlani S, Tomai F, De Paulis R, Turani F, Colella DF, Nardi P, et al. Preoperative shift from glibenclamide to insulin is cardioprotective in diabetic patients undergoing coronary artery bypass surgery. J Cardiovasc Surg (Torino) 2004;45:117-22.
63. Schultz JJ, Hsu AK, Gross GJ. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart. J Mol Cell Cardiol 1997;29:2187-95.
64. Schultz JE, Hsu AK, Gross GJ. Ischemic preconditioning in the intact rat heart is mediated by delta1 - but not mu- or kappa-opioid receptors. Circulation 1998;97:1282-9.
65. Schultz J el-L, Hsu AK, Nagase H, Gross GJ. TAN-67, a delta 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels. Am J Physiol 1998;274:H909-14.
66. Bell SP, Sack MN, Patel A, Opie LH, Yellon DM. Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol 2000;36:2296-302.
67. McPherson BC, Yao Z. Morphine mimics preconditioning via free radical signals and mitochondrial K(ATP) channels in myocytes. Circulation 2001;103:290-5.